RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF ATORVASTATIN AND EZETIMIBE IN PHARMACEUTICAL DOSAGE FORM

Journal Title: Asian Journal of Pharamceutical and Clinical Research - Year 2015, Vol 8, Issue 2

Abstract

 Objective: The aim was to develop a simple, selective, linear, precise, and accurate reverse phase high performance liquid chromatography methodfor simultaneous estimation of atorvastatin and ezetimibe in tablet dosage form.Methods: The chromatographic separation was performed using hypersil BDS C18 coloumn (250 mm × 4.6 mm, 5 mm particle size). Mobile phasecomposed of phosphate buffer pH-4.5 and acetonitrile (35:65 v/v) at a flow rate of 1 ml/min. Detection was carried out using photodiode arraydetector at 228 nm. The method was validated as per ICH guidelines.Results: The retention time for atorvastatin and ezetimibe are observed as 2.36 and 3.43 minutes respectively. Linearity range was observed inconcentration of 12.5-75 μg/ml for both atorvastatin and ezetimibe. The percentage recoveries of atorvastatin and ezetimibe are 100.21% and100.22% respectively. The correlation coefficients for both the components are close to 1.Conclusion: This method is simple, selective, linear, precise, accurate and sensitive hence can be successfully employed for the routine quality controlof dosage forms containing both the drugs in pharmaceutical industries.Keywords: Reverse transcription polymerase chain reaction, Method development, Atorvastatin, Ezetimibe, Validation.

Authors and Affiliations

Saroj Kumar Raul, Ratna Bhaskar Aravelli, Durgasi Jhansi

Keywords

Related Articles

FORMULATION AND EVALUATION OF NOVEL CHROMENE DERIVATIVE AS AN ANTI INFLAMMATORY AGENT USED FOR IBD

Objective: To formulate and evaluate an extended-release (ER) tablet of a new molecule, 2-amino-4-(4-bromophenyl)-7-hydroxy-4H-chromene-3- carbonitrile using a combination of two polymers (hydroxypropyl methyl cellulose...

DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL OF KAEMPFERIA GALANGA L EXTRACT AS AN ANTI-INFLAMMATION (PROSTAGLANDIN E2 AND TUMOR NECROSIS FACTOR ALPHA) ON OSTEOARTHRITIS

Objective: The purpose of this study was to compare the effectiveness of the rhizome extract against inflammatory markers such as tumor necrosis factor (TNF)-alpha and prostaglandin E2 (PGE2) with meloxicam in patients w...

EVALUAION OF ANTI-INFLAMMATORY AND ANTI PYRETIC ACTIVITY OF ETHANOLIC LEAVES EXTRACT OF Myxopyrum smilacifolium (Wall.) Blume

ABSTRACTObjective: The aim of this study was to evaluate the anti-inflammatory and antipyretic activity of ethanolic extract of Myxopyrum smilacifolium(EEMS) leaves in experimental animals.Methods: Plant material was col...

ANALYTICAL METHOD DEVELOPMENT & VALIDATION OF ETRAVIRINE IN ITS BULK DOSAGE FORM BY USING RP-HPLC METHOD AS PER ICH GUIDELINES

 Objective: An accurate, precise, rapid and economical reverse phase high performance liquid chromatography (HPLC) method has been developedand validated for the estimation of etravirine in pharmaceutical dosage forms,...

PLEIOTROPIC ROLE OF SIMVASTATIN AND ALENDRONATE ON MESENCHYMAL STEM CELLS

Objectives: Previously, our research group has investigated the effect of alendronate (ALN) and simvastatin (SV) in their minimum inhibitory dose (IC50) on oral squamous cell carcinoma cell line where inhibition of angio...

Download PDF file
  • EP ID EP605667
  • DOI -
  • Views 88
  • Downloads 0

How To Cite

Saroj Kumar Raul, Ratna Bhaskar Aravelli, Durgasi Jhansi (2015). RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF ATORVASTATIN AND EZETIMIBE IN PHARMACEUTICAL DOSAGE FORM. Asian Journal of Pharamceutical and Clinical Research, 8(2), 178-181. https://europub.co.uk/articles/-A-605667